Alpha-naphthoflavone induces vasorelaxation through the induction of extracellular calcium influx and NO formation in endothelium

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 5, 2003, Pages 377-385

  Cheng, Yu Wen ^b   Li, Ching Hao ^a   Lee, Chen Chen ^a   Kang, Jaw Jou ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Ca2+; Endothelium; Naphthoflavone; NO

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; ALPHA NAPHTHOFLAVONE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CHELATING AGENT; CYCLIC AMP; CYCLIC GMP; EGTAZIC ACID; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NICKEL; NITRIC OXIDE; PHENYLEPHRINE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; CALCIUM TRANSPORT; CELL CULTURE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; MALE; MEASUREMENT; NONHUMAN; RAT; THORACIC AORTA; UMBILICAL VEIN; VASODILATATION;

ANIMALS; AORTA, THORACIC; BENZOFLAVONES; BETA-NAPHTHOFLAVONE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR; UMBILICAL VEINS; VASODILATION; VASODILATOR AGENTS;

EID: 0344944883     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0820-6     Document Type: Article

References (96)

1. Alcaraz MJ, Hoult JRS (1985) Actions of flavonoids and the novel anti-inflammatory flavone, hypolaetin-8-glucoside on prostaglandin biosynthesis and inactivation. Biochem Pharmacol 34:2477-2482
2. Andries MJ, Lucier GW, Goldstein J, Tompson CL (1990) Involvement of cytochrome P-450c in α-naphthoflavone metabolism by rat liver microsomes. Mol Pharmacol 37:990-995
3. Balestrieri M.L, Castaldo D, Balestrieri C, Quagliuilo L, Giovane A, Servillo L (2003) Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. J Lipid Res 44:380-387
4. Benson AM, Hunkeler MJ, Talalay P (1980) Increase of NAD(P)H: quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 77:5216-5220
5. Birt DF, Walker D, Tibbles MB, Bresnick K (1986) Anti-mutagens and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis 7:959-963
6. Bossu JL, Elhamdani A, Feltz A (1992a) Voltage-dependent calcium entry in confluent bovine capillary endothelial cells. FEBS Lett 299:239-242
7. Bossu JL, Elhamdani A, Feltz A, Tanzi F, Aunis D, Thierse D (1992b) Voltage-gated Ca entry in isolated bovine capillary endothelial cells: evidence of a new type of BAY K8644-sensitive channel. Pflugers Arch 420:200-207
8. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome O-450 reductase. Nature 351:714-718
9. Buening MK, Chang RL, Huang ML, Former JC, Wood AW, Conney AH (1981) Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res 41:67-72
10. Cheng YW, Kang JJ (1997) Mechanism of vasorelaxation of thoracic aorta caused by xanthone. Eur J Pharmacol 336:23-28
11. 4 induced microsomal lipid peroxidation. Experientia 47:195-199
12. Cobb JP, Cunnion RE, Danner RL (1993) Nitric oxide as a target for therapy in septic shock. Crit Care Med 21:1261-1263
13. Das A, Wang JH, Lien EJ (1994) Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relation (SSAR) analysis. Prog Drug Res 42:133-166
14. De Groot H, Rauen U (1998) Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol 12:249-255
15. De Whalley CV, Rankin SM, Hoult JRS, Jessup W, Lerke DE (1990) Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 39:1743-1750
16. Diamond L, Gelboin HV (1969) Alpha-naphthoflavone: an inhibitor of hydrocarbon cytotoxicity and microsomal hydroxylase. Science 166:1023-1025
17. Ding Y, Vaziri ND (2000) Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric oxide synthase expression. J Pharmacol Exp Ther 292:606-609
18. Dong W, Teraoka H, Kondo S, Hiraga T (2001) 2,3,7,8-Tetrachlorodibenzo-p- dioxin induces apoptosis in the dorsal mid-brain of zebrafish embryos by activation of aryl hydrocarbon receptor. Neurosci Lett 303:169-172
19. Duarte J, Perez-Vizcaino F, Utrilla P, Jimenez J, Tamargo J, Zarzuelo A (1993a) Vasodilatory effects of flavonoids in rat aortic smooth muscle: structure-activity relationships. Gen Pharmacol 24:857-862
20. Duarte J, Perez-Vizcaino F, Zarzuello A, Jimenez J, Tamargo J (1993b) Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur J Pharmacol 239:1-7
21. Duffy SJ, Vita JA (2003) Effects of phenolics on vascular endothelial function. Curr Opin Lipidol 14:21-27
22. Ewing JF, Janero DR (1998) Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium (III) reduction and ozone-chemiluminescent detection. Free Radic Biol Med 25:621-628
23. Fawzy AA, Vishwanath BS, Franson RC (1988) Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action. Agents Actions 25:394-400
24. Ferriola PC, Cody V, Middleton E Jr (1989) Protein kinase C inhibition by flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38:1617-1624
25. Fitzpatrick DF, Hirschfield SL, Coffey RG (1993) Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265:H774-H778
26. Formica JV, Regelson W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33:1061-1080
27. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE (1993a) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 34:454-457
28. Frankel EN, Waterhouse AL, Kinsella JE (1993b) Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103-1104
29. Furchgott RF (1984) The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 24:175-197
30. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376
31. Furchgott RF, Cherry PD, Zawadzki JV, Jothianandan D (1984) Endothelial cells as mediators of vasodilation of arteries. J Cardiovasc Pharmacol 6 (Suppl 2):S336-S343
32. 2+-independent regulation of smooth muscle contraction. J Muscle Res Cell Motil 23:47-52
33. Gewaltig MT, Kojda G (2002) Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 55:250-260
34. Gordon GB, Prochaska HJ, Yang LYS (1991) Inhibition of NAD(P)H:quinone reductase in human peripheral blood lymphocytes. Carcinogenesis 12:2393-2396
35. 2+ entry in human and bovine endothelial cells. J Physiol (Lond) 482:259-274
36. Gryglewski RJ, Korbut R, Robak J, Swies J (1987). On the mechanism of anti-thrombotic action of flavonoids. Biochem Pharmacol 36:317-322
37. Guengerich FP, Kim DH (1990) In vitro inhibition of dihydropyridine oxidation and AFB1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 11:2275-2279
38. Hanasaki Y, Ogawa S, Fukui S (1994) The correlation between active oxygen scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 16:845-850
39. Heo MY, Yu KS, Kim H, Kim HP, Au WW (1992) Anticlastogenic effect of flavonoids against mutagen-induced micronuclei in mice. Mutat Res 284:243-249
40. Hu CM, Cheng HW, Cheng YW, Kang JJ (2001) Mechanisms underlying the induction of vasorelaxation in rat thoracic aorta by sanguinarine. Jpn J Pharmacol 85:47-53
41. Ignarro LJ, Sisodia M, Trinh K, Bedrood S, Wu G, Wei LH, Buga GM (2002) Nebivolol inhibits vascular smooth muscle cell proliferation by mechanisms involving nitric oxide but not cyclic GMP. Nitric Oxide 7:83-90
42. 2+ entrance via cation currents in endothelial cells. Life Sci 56:11-17
43. Iyengar R, Stuehr DJ, Marletta MA (1985) Macrophage synthesis of nitrite, nitrate and N-nitrosamines: precursors and role of respiratory burst. Proc Natl Acad Sci USA 84:6369-6373
44. Jaffe EA (1985) Physiologic functions of normal endothelial cells. Ann NY Acad Sci 454:279-291
45. Janel N, Dosne AM, Obert B, Meyer D, Kerbiriou-Nabias D (1997) Functional characterization of bovine von Willebrand factor gene promoter in bovine endothelial cells demonstrates species-specific properties. Gene 198:127-134
46. Jeon YJ, Youk ES, Lee SH, Suh J, Na YJ, Kim HM (2002) Polychlorinated biphenyl-induced apoptosis of murine spleen cells is aryl hydrocarbon receptor independent but caspases dependent. Toxicol Appl Pharmacol 181:69-78
47. Jimenez R, Anderiambeloson E, Duarte J, Andriantsitohaina R, Jimenez J, Perez-Zicaino F, Zarzuelo A, Tamargo J (1999) Involvement of thromboxane A2 in the endothelium-dependent contraction induced by myricetin in rat isolated aorta. Br J Pharmacol 127:1539-1544
48. Kanazawa K, Yamashita T, Ashida H, Danno G (1998) Antimuta-genicity of flavones and flavonols to heterocyclic amines by specific and strong inhibition of the cytochrome P450 1A family. Biosci Biotechnol Biochem 62:970-977
49. Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen MK (1987) In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J Pharmacol Exp Ther 242:864-872
50. Kerry NL, Abbey M (1997) Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis 135:93-102
51. Kerwin JF Jr, Heller M (1994) The arginine-nitric oxide pathway: a target for new drugs. Med Res Rev 14:23-74
52. Kim SH, Kang KW, Kim KW, Kim ND (2000) Procyanidins in Cratagus extract evokes endothelium-dependent vasorelaxation in rat aorta. Life Sci 67:121-131
53. Kinoshita N, Gelboin HV (1972) Aryl hydrocarbon hydroxylase and polycyclic hydrocarbon tumorigenesis: effect of the enzyme inhibitor 7,8-benzoflavone on tumorigenesis and macromolecular binding. Proc Natl Acad Sci USA 69:824-828
54. Lanza F, Bereta A, Stierle A, Corre G, Cazenave JP (1987) Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization. Thromb Res 45:477-484
55. 2+ in intact valvular endothelium from rabbits. Am J Physiol 270:H837-H848
56. Li Y, Wang E, Patten CJ, Chen L, Yang CS (1994) Effects of flavonoids on cytochrome P-450 dependent acetaminophen metabolism in rat and human liver microsomes. Drug Metab Dispos 22:566-571
57. Lincolin TM, Cornwell TL (1991) Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 28:129-137
58. 2+ by cAMP in vascular SMC. Am J Physiol 258:C399-C407
59. Low AM, Berdik M, Sormaz L, Gataianece S, Buchanan MR, Kwan CY, Daniel EE (1996) Plant alkaloids, tetrandrine and dernandezine, inhibit calcium-depletion stimulated calcium entry in human and bovine endothelial cells. Life Science 58:2327-2335
60. Lowry OH, Rosebrough NJ, Farr AL, Randall RL (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
61. Luscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz K, Stulz P, Von SL, Yang ZH, Turina M, Gradel E, Weber E (1988) Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 319:462-467
62. 2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem Biophys Res Commun 164:678-685
63. Middleton EJ (1998) Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 439:175-182
64. Millanvoye-Vanbrussel E, David-Dufilho M, Pham TD, Iouzalen L, Aude Devynck M (1999). Regulation of arachidonic acid release by calcium influx in human endothelial cells. J Vasc Res 36:235-244
65. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
66. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142
67. Moroney MA, Alcaraz MJ, Forder RA, Carey F, Hoult JRS (1988) Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J Pharm Pharmacol 40:787-792
68. Muraki K, Watanabe M, Imaizumi Y (2000) Nifedipine and nisoldipine modulate membrane potential of vascular endothelium via a myo-endothelial pathway. Life Sci 67:3163-3170
69. Nijhoff WA, Groen GM, Peter HM (1993) Induction of rat hepatic and intestinal glutathione S-transferases and glutathione by dietary naturally occurring anticarcinogens. Int J Oncol 3:1131-1139
70. Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature: 327:524-526
71. Palmer RM, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666
72. Ramon Sanchez de Rojas V, Somoza B, Ortega T, Villar AM, Tejerina T (1999) Vasodilatory effect in rat aorta of eriodictyol obtained from Satureja obovata. Planta Med 65:234-238
73. Rankin SM, Leake LS (1988) The modification of low-density lipoprotein by macrophage, by oxidation or proteolysis. Agents Actions Suppl 26:233-239
74. Renaud S, DeLorgeril M (1992) Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 339:1523-1526
75. Revuelta MP, Hidalgo A, Cantabrana B (1999) Involvement of cAMP and beta-adrenoceptors in the relaxing effect elicited by flavonoids on rat uterine smooth muscle. J Auton Pharmacol 19:353-358
76. Rodgers EH, Grant MH (1998) The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF-7 human breast cancer cells. Chem Biol Interact 116:213-228
77. Rosenkranz-Weiss P, Sessa WC, Millstien S, Kaufman S, Watson CA, Pober JS (1994) Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 93:2236-2243
78. Sessa WC, Harrison JK, Barber CM (1992) Molecular cloning of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 267:15274-15276
79. Shimada T, Yamazaki H, Foroozesh M, Hopkins NE, Alworth WL, Guengerich FP (1998) Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, and 1B1. Chem Res Toxicol 11:1048-1056
80. Shou M, Grogan J, Mancewicz, JA, Krausz KW, Gonzalez FJ, Gelboin HV, Korzekwa KR (1994) Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry 33:6450-6455
81. Siess MH, Leelerc J, Canivenc-Lavier MC, Rat P, Suschetet M (1995) Heterogenous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes. Toxicol Appl Pharmacol 130:73-78
82. Silveira LA, Smith JL, Tan JL, Spudich JA (1998) MLCK-A, an unconventional myosin light chain kinase from Dictyostelium, is activated by a cGMP-dependent pathway. Proc Natl Acad Sci USA 95:13000-13005
83. Sousa LR, Marletta MA (1985) Inhibition of cytochrome P450 activity in rat liver microsomes by the naturally occurring flavonoid quercetin. Arch Biochem Biophys 240:345-357
84. Staples JE, Murante FG, Fiore NC, Gasiewicz TA, Silverstone AE (1998) Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. J Immunol 160:3844-3854
85. Tassaneeyakul W, Birkett DJ, Veronese ME, Mcmanus ME, Tukey RH, Quattrochi LC, Gelboin HV, Miners JO (1993) Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J Pharmacol Exp Ther 265:401-407
86. Trigueiro F, Cortes SF, Almeida RN, Lemos VS (2000) Endothelium- independent vasorelaxant effect of dioclein, a new flavonoid isolated from Dioclea grandiflora, in the rat aorta. J Pharm Pharmacol. 52:1431-1434
87. Tzeng SH, Ko WC, Ko FN, Teng CM (1991) Inhibition of platelet aggregation by some flavonoids. Thromb Res 64:91-100
88. 2+ influx mechanism responsible for endothelium-dependent relaxation. Res Commun Mol Pathol Pharmacol 104:127-144
89. Vanhoutte PM, Rubanyi GM, Miller VM, Houston DS (1986) Modulation of vascular smooth muscle contraction by endothelium. Annu Rev Physiol 48:307-330
90. Wang X, Chu W, van Breemen C (1996) Potentiation of acetylcholine- induced responses in freshly isolated rabbit aortic endothelial cells. J Vasc Res 33:414-424
91. Wei H, Tye L, Bresnick E, Birt DF (1990) Effect of apigenin a plant flavonoid on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50:499-502
92. Xie Q, Zhang Y, Zhai, C, Bonanno JA (2002) Calcium influx factor from cytochrome P450 metabolism and secretion-like coupling mechanisms for capacitative calcium entry in corneal endothelial cells. J Biol Chem 277:16559-16566
93. Xie QW, Cho HJ, Calaycay J (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228
94. 2+ channels in cerebral microvascular endothelial cells and ET-1 biosynthesis. Am J Physiol 283:C1687-C1695
95. 2+ entry into vascular endothelial cells. FASEB J 14:932-938
96. Youdim KM, McDonald J, Kalt W, Joseph JA (2002) Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J Nutr Biochem 13:282-288